logo image
search icon
Catheters and Active Implantable CDMO Market

Catheters and Active Implantable CDMO Market Size, Share & Trends Analysis Distribution by Service Category (Catheters (Cardiac Catheters, Urology Catheters, Neurovascular Catheters) Active Implantable Devices (Neuromodulation Devices, Structural Heart Devices, Heart Failure Devices, Urology Implantable Devices), Endoscopy Devices), End User- and Segment Forecasts, 2024-2031

Report ID : 2830 | Published : 2024-10-07 | Pages: 170 | Format: PDF/EXCEL/Power BI Dashbord

The Catheters and Active Implantable CDMO Market Size is valued at USD 7.01 Bn in 2023 and is predicted to reach USD 14.12 Bn by the year 2031 at an 9.4% CAGR during the forecast period for 2024-2031.

Catheter and implantable

Catheters and Active Implantable CDMO is a significant market in the health care business, which develops and manufactures critical medical devices. A catheter is a flexible tube that assists in the drainage of fluids or administration of medication, with monitoring for various bodily functions, thus greatly contributing to the cure of diseases such as cardiovascular diseases and diabetes. Active implantable devices are placed in various parts of the body and must be powered by an external source, including cardiac pacemakers, defibrillators, and neurostimulators. Such devices monitor physiological parameters and deliver targeted therapies aimed at improving the patient's outcomes as well as quality of life.

Contract Development and Manufacturing Organizations (CDMOs) that specialize in catheters and AIDs supply critical design, development, and large-volume manufacturing of these products. Such CDMOs play an extremely critical role in meeting all the requirements of regulations while maintaining innovation as well as cost-effectiveness. The increasing numbers of medical device companies involved in outsourcing their manufacturing represent a major growth factor, as this move allows them to focus more on core competencies. Demand is increasing for advanced catheter technologies and AIDs propelled by an aging population worldwide and shifting needs in healthcare that are likely to fuel market growth soon.

Competitive Landscape

Some of the Key Players in Catheters and Active Implantable CDMO Market:

  • Integer Holdings Corporation (US)
  • Cirtec (US)
  • Biomerics (US)
  • Switchback Medical (US)
  • Velentium LLC (US)
  • Heraeus Group (Germany)
  • Zeus Company LLC (US)
  • Veranex (US)
  • Freudenberg Medical (US)
  • Medeologix (Taiwan)

Market Segmentation:

The catheters and active implantable CDMO market is segmented by service category, end user. By service category the market is segmented into catheters, active implantable devices, endoscopy devices, others. Catheters is sub segmented into cardiac catheters, urology catheters, neurovascular catheters, others. Active implantable devices is sub segmented into neuromodulation devices, structural heart devices, heart failure devices, urology implantable devices, others. Neuromodulation devices is sub segmented into spinal cord stimulators, deep brain stimulators, others. Structural heart devices is sub segmented into valve implants, stents and shunts, others.  Heart failure devices percutaneous left ventricular assist device (LVAD), percutaneous right ventricular support devices (RVAD), others. By end user the market is categorized into medical device OEM companies, academic and research institutes, government agencies.

Active Implantable Devices Segment is Expected to Drive the Catheters and Active Implantable CDMO Market

The Catheters and Active Implantable CDMO Market is primarily driven by the active implantable devices segment, experiencing robust growth due to several factors. Growing prevalence rates of chronic diseases, including cardiovascular and neurological conditions like heart failure, arrhythmias, and epilepsy, are rising the demand for products including the implantable cardioverter-defibrillator and neurostimulator. The efficiency of these devices, communication through wireless means, and biocompatibility of the materials used are making them more and more effective and user-friendly. Remote monitoring of patients is one such feature that has contributed positively to the outcome. Another driver is the aging population, who are more prone to chronic conditions that would continue to be there for a long time, thereby boosting demand for active implantable devices, as healthcare systems start to grapple with this demographic change.

Medical Device OEM Companies is Growing at the Highest Rate in the Catheters and Active Implantable CDMO Market.

The primary growth driver for the market for catheters and active implantable CDMO is medical device OEM companies, which is one of the largest segment categories. These companies have always been pioneers for innovative development in medical technology, with specific focus areas being catheters and active implantable products. These areas alone create such mass demand for new products that growth has been primarily led by this type of company. Further, outsourcing of manufacturing operations to CDMOs allows OEMs to concentrate better on core competencies such as research and development with the added advantage of being able to capitalize on CDMO capabilities, thus increasing efficiency and shortening time-to-market. Complexity in regulatory compliance in medical devices also compels OEMs to work with a CDMO to assure their products meet very strict quality and safety standards.

Regionally, Asia-Pacific Led the Catheters and Active Implantable CDMO Market.

Active implantable CDMO market in catheters primarily is led by the North America region which has been driven by some key factors. More advanced catheter and implantable device technology developed by the leading medical device companies augments the portfolio of the patient's outcomes for better recovery. Innovation with safety and efficacy also assists this region. Better healthcare infrastructure, more developed hospitals, and research centers are the main emerging grounds in North America for adopting new technologies. Growing healthcare needs primarily due to an older population and a high prevalence of chronic diseases, such as cardiovascular diseases, boost the demand for catheters and active implantable devices in the region.

Catheters and Active Implantable CDMO Market Report Scope

Report Attribute

Specifications

Market Size Value In 2023

USD 7.01 Bn

Revenue Forecast In 2031

USD 14.12 Bn

Growth Rate CAGR

CAGR of 9.4% from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Bn and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Service Category, End User, and By Region

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; Southeast Asia

Competitive Landscape

Integer Holdings Corporation (US), Cirtec (US), Biomerics (US), Switchback Medical (US), Velentium LLC (US), Heraeus Group (Germany), Zeus Company LLC (US), Veranex (US), Freudenberg Medical (US), Medeologix (Taiwan)

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape.                     

Pricing and Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1.          Methodology and Scope

1.1.        Research Methodology

1.2.        Research Scope & Assumptions

Chapter 2.          Executive Summary

Chapter 3.          Global Catheters and Active Implantable CDMO Market Snapshot

Chapter 4.          Global Catheters and Active Implantable CDMO Market Variables, Trends & Scope

4.1.        Market Segmentation & Scope

4.2.        Drivers

4.3.        Challenges

4.4.        Trends

4.5.        Investment and Funding Analysis

4.6.        Porter's Five Forces Analysis

4.7.        Incremental Opportunity Analysis (US$ MN), 2024-2031

4.8.        Global Catheters and Active Implantable CDMO Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031

4.9.        Competitive Landscape & Market Share Analysis, By Key Player (2023)

4.10.     Use/impact of AI on Catheters and Active Implantable CDMO Industry Trends

Chapter 5.          Catheters and Active Implantable CDMO Market Segmentation 1: By Service Category, Estimates & Trend Analysis

5.1.        Market Share by Service Category, 2023 & 2031

5.2.        Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Service Category:

5.2.1.    Catheters

5.2.1.1. Cardiac Catheters

5.2.1.2. Urology Catheters

5.2.1.3. Neurovascular Catheters

5.2.1.4. Others

5.2.2.    Active Implantable Devices

5.2.2.1. Neuromodulation Devices

5.2.2.1.1.            Spinal Cord Stimulators

5.2.2.1.2.            Deep Brain Stimulators

5.2.2.1.3.            Others

5.2.2.2. Structural Heart Devices

5.2.2.2.1.            Valve Implants

5.2.2.2.2.            Stents and Shunts

5.2.2.2.3.            Others

5.2.2.3. Heart Failure Devices

5.2.2.3.1.            Percutaneous Left Ventricular Assist Device (LVAD)

5.2.2.3.2.            Percutaneous Right Ventricular Support Devices (RVAD)

5.2.2.3.3.            Others

5.2.2.4. Urology Implantable Devices

5.2.2.5. Others

5.2.3.    Endoscopy Devices

5.2.4.    Others

Chapter 6.          Catheters and Active Implantable CDMO Market Segmentation 2: By End-user, Estimates & Trend Analysis

6.1.        Market Share by End-user, 2023 & 2031

6.2.        Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following End-users:

6.2.1.    Medical Device OEM Companies

6.2.2.    Academic and Research Institutes

6.2.3.    Government Agencies

Chapter 7.          Catheters and Active Implantable CDMO Market Segmentation 3: Regional Estimates & Trend Analysis

7.1.        Global Catheters and Active Implantable CDMO Market, Regional Snapshot 2023 & 2031

7.2.        North America

7.2.1.    North America Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031

7.2.1.1. US

7.2.1.2. Canada

7.2.2.    North America Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service Category, 2024-2031

7.2.3.    North America Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031

7.3.        Europe

7.3.1.    Europe Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031

7.3.1.1. Germany

7.3.1.2. U.K.

7.3.1.3. France

7.3.1.4. Italy

7.3.1.5. Spain

7.3.1.6. Rest of Europe

7.3.2.    Europe Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service Category, 2024-2031

7.3.3.    Europe Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031

7.4.        Asia Pacific

7.4.1.    Asia Pacific Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031

7.4.1.1. India

7.4.1.2. China

7.4.1.3. Japan

7.4.1.4. Australia

7.4.1.5. South Korea

7.4.1.6. Hong Kong

7.4.1.7. Southeast Asia

7.4.1.8. Rest of Asia Pacific

7.4.2.    Asia Pacific Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service Category, 2024-2031

7.4.3.    Asia Pacific Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts By End-user, 2024-2031

7.5.        Latin America

7.5.1.    Latin America Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031

7.5.1.1. Brazil

7.5.1.2. Mexico

7.5.1.3. Rest of Latin America

7.5.2.    Latin America Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service Category, 2024-2031

7.5.3.    Latin America Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031

7.6.        Middle East & Africa

7.6.1.    Middle East & Africa Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

7.6.1.1. GCC Countries

7.6.1.2. Israel

7.6.1.3. South Africa

7.6.1.4. Rest of Middle East and Africa

7.6.2.    Middle East & Africa Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service Category, 2024-2031

7.6.3.    Middle East & Africa Catheters and Active Implantable CDMO Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031

Chapter 8.          Competitive Landscape

8.1.        Major Mergers and Acquisitions/Strategic Alliances

8.2.        Company Profiles

 

8.2.1.    Integer Holdings Corporation (US)

8.2.1.1. Business Overview

8.2.1.2. Key Product/Service Offerings

8.2.1.3. Financial Performance

8.2.1.4. Geographical Presence

8.2.1.5. Recent Developments with Business Strategy

8.2.2.    Cirtec (US)

8.2.3.    Biomerics (US)

8.2.4.    Switchback Medical (US)

8.2.5.    Velentium LLC (US)

8.2.6.    Heraeus Group (Germany)

8.2.7.    Zeus Company LLC (US)

8.2.8.    Veranex (US)

8.2.9.    Freudenberg Medical (US)

8.2.10.  Medeologix (Taiwan)

8.2.11.  Other Prominent Players

Segmentation of Catheters and Active Implantable CDMO Market -

Catheters and Active Implantable CDMO Market by Service Category -

  • Catheters
    • Cardiac Catheters
    • Urology Catheters
    • Neurovascular Catheters
    • Others
  • Active Implantable Devices
    • Neuromodulation Devices
      • Spinal Cord Stimulators
      • Deep Brain Stimulators
      • Others
    • Structural Heart Devices
      • Valve Implants
      • Stents and Shunts
      • Others
    • Heart Failure Devices
      • Percutaneous Left Ventricular Assist Device (LVAD)
      • Percutaneous Right Ventricular Support Devices (RVAD)
      • Others
    • Urology Implantable Devices
    • Others
  • Endoscopy Devices
  • Others

catheter and implantable

Catheters and Active Implantable CDMO Market by End-user -

  • Medical Device OEM Companies
  • Academic and Research Institutes
  • Government Agencies

Catheters and Active Implantable CDMO Market by Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

 

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Catheters and Active Implantable CDMO Market Size?

The Catheters and Active Implantable CDMO Market is expected to grow at an 9.4% CAGR during the forecast period for 2024-2031.

Integer Holdings Corporation (US), Cirtec (US), Biomerics (US), Switchback Medical (US), Velentium LLC (US), Heraeus Group (Germany), Zeus Company LLC

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Medical Devices

Report License Selection

Determine the appropriate license for your report

Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach